FDA approves long-delayed Boston Scientific stent (AP via Yahoo! Finance)
Boston Scientific Corp. said Friday the Food and Drug Administration approved its long-delayed follow-up to the drug-coated stent Taxus.

After Ranbaxy, US FDA turns the heat on Actavis (Business Standard India)
The US Congressional committee, which is inquiring into the country's Food and Drug Administration s (FDA) handling of drug-marketing approvals of India s leading drug-maker Ranbaxy, has extended its probe into similar permissions given to Iceland s Actavis.